Patents Represented by Attorney, Agent or Law Firm Maurice M. Klee, Ph.D.
  • Patent number: 6620370
    Abstract: Plasma addressed liquid crystal display ribs are formed by a method which includes forming a temporary mask on portions of a surface of a substrate, depositing a layer of a glass paste having a curable medium and at least one pigment blended therein over the substrate and temporary mask, micro-molding rib structures from the glass paste on the substrate surface in areas between the masked sections, removing any residual layer of paste material present on the temporary mask, removing the temporary mask from the substrate, and firing the substrate with micro-molded rib structures thereon.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: September 16, 2003
    Assignee: Corning Incorporated
    Inventor: Jean-Pierre Themont
  • Patent number: 5562904
    Abstract: Methods and compositions are provided for facilitating gene therapy procedures involving the transduction of target cells with retroviral vector particles in the presence of complement containing body fluids. The administration of soluble complement inhibitor molecules to body fluids prevents the complement mediated inactivation of the retroviral vector particles, and provides a safety mechanism for such gene therapy procedures, as the action of soluble complement inhibitors is transient, and any retroviral vector particles present after the return of uninhibited complement activity will be inactivated. Preferred soluble complement inhibitors for use in the practice of the present invention include complement inhibitory anti-complement component mAbs (including complement inhibitory anti C5 antibodies).
    Type: Grant
    Filed: July 21, 1994
    Date of Patent: October 8, 1996
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Russell P. Rother, Scott A. Rollins, James M. Mason, Stephen P. Squinto